Published in TB and Outbreaks Week, January 23rd, 2001
"We haven't had any totally new antibiotics in a long time," said first author Dennis L. Stevens, MD, PhD, Boise Veterans Affairs Medical Center and University of Washington School of Medicine. "Linezolid has an entirely different mechanism of action and looks like it can get some of the resistant bugs," he said. "It's a new cannon in our arsenal."
In a multi-center study, Stevens and his...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week